Why would they do any other work on recaf until the patent was in place!Daaa-But they still have a license agreement with BioCurex if and when they chose to use it,and they dont have to pay out any more money until they hit a milestone payment or Royalty.Pretty Dang smart of ABT if you ask me.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.